These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32857720)

  • 1. The cytochrome 11B2 aldosterone synthase gene rs1799998 single nucleotide polymorphism determines elevated aldosterone, higher blood pressure, and reduced glomerular filtration, especially in diabetic female patients.
    Sydorchuk L; Dzhuryak V; Sydorchuk A; Levytska S; Petrynych V; Knut R; Kshanovska A; Iftoda O; Tkachuk O; Kyfiak P; Popovich A; Khomko O; Sydorchuk R
    Endocr Regul; 2020 Jul; 54(3):217-226. PubMed ID: 32857720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone synthase (CYP11B2) -344T/C polymorphism is not associated with the initiation and progression of diabetic nephropathy in Caucasian Type 1 diabetic patients.
    Lajer M; Schjoedt KJ; Jacobsen P; Tarnow L; Parving HH
    Diabet Med; 2006 Jun; 23(6):675-80. PubMed ID: 16759311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.
    Schjoedt KJ; Lajer M; Andersen S; Tarnow L; Rossing P; Parving HH
    Scand J Clin Lab Invest; 2006; 66(3):173-80. PubMed ID: 16714246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of aldosterone synthase CYP11B2 (-344C/T) gene polymorphism with essential hypertension and left ventricular hypertrophy in the Egyptian population.
    Abdel Ghafar MT
    Clin Exp Hypertens; 2019; 41(8):779-786. PubMed ID: 30561227
    [No Abstract]   [Full Text] [Related]  

  • 5. Aldosterone Synthase CYP11B2 Gene Promoter Polymorphism in a Turkish Population With Chronic Kidney Disease.
    Yilmaz M; Sari I; Bagci B; Gumus E; Ozdemir O
    Iran J Kidney Dis; 2015 May; 9(3):209-14. PubMed ID: 25957425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin-aldosterone system gene polymorphisms and coronary artery disease: detection of gene-gene and gene-environment interactions.
    Jia EZ; Xu ZX; Guo CY; Li L; Gu Y; Zhu TB; Wang LS; Cao KJ; Ma WZ; Yang ZJ
    Cell Physiol Biochem; 2012; 29(3-4):443-52. PubMed ID: 22508051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Promoter variants of aldosterone synthase gene (CYP11B2) and salt-sensitivity of blood pressure].
    Wrona A; Widecka K; Adler G; Czekalski S; Ciechanowicz A
    Pol Arch Med Wewn; 2004 Feb; 111(2):191-7. PubMed ID: 15230231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of Genetic Polymorphisms of Aldosterone Synthase Gene Cytochrome P450 11B2 and Mineralocorticoid Receptors with Coronary Artery Disease in Taiwan.
    Chou CH; Ueng KC; Yang SF; Wu CH; Wang PH
    Int J Med Sci; 2016; 13(2):117-23. PubMed ID: 26941570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese.
    Tamaki S; Iwai N; Tsujita Y; Kinoshita M
    Hypertension; 1999 Jan; 33(1 Pt 2):266-70. PubMed ID: 9931115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the ACE (rs1799752) and CYP11B2 (rs1799998) Gene Polymorphisms to Atrial Fibrillation in the Tunisian Population.
    Gouissem I; Midani F; Soualmia H; Bouchemi M; Ouali S; Kallele A; Romdhane NB; Mourali MS; Feki M
    Biol Res Nurs; 2022 Jan; 24(1):31-39. PubMed ID: 34227426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of renin-angiotensin-aldosterone system gene variants on the severity of hypertension in patients with newly diagnosed hypertension.
    Tiago AD; Badenhorst D; Nkeh B; Candy GP; Brooksbank R; Sareli P; Libhaber E; Samani NJ; Woodiwiss AJ; Norton GR
    Am J Hypertens; 2003 Dec; 16(12):1006-10. PubMed ID: 14643573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of gene polymorphisms of the renin-angiotensin-aldosterone system on essential hypertension in Kazakhs in Xinjiang.
    Niu S; Zhang B; Zhang K; Zhu P; Li J; Sun Y; He N; Zhang M; Gao Z; Li X; Simayi A; Ge J; Cong M; Zhou W; Qiu C
    Clin Exp Hypertens; 2016; 38(1):63-70. PubMed ID: 26305278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the C-344T aldosterone synthase gene variant with essential hypertension: a meta-analysis.
    Sookoian S; Gianotti TF; González CD; Pirola CJ
    J Hypertens; 2007 Jan; 25(1):5-13. PubMed ID: 17143166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the aldosterone synthase gene -344T>C polymorphism with essential hypertension and glucose homeostasis: a case-control study in a Han Chinese population.
    Li XM; Ling Y; Lu DR; Lu ZQ; Yi QL; Liu Y; Chen HY; Gao X
    Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):598-604. PubMed ID: 21682760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of aldosterone levels by aldosterone synthase promoter polymorphism and association with eGFR decline in patients with chronic kidney disease.
    Qian J; Zhong J; Yan M; Shi H; Hao C; Gu Y; Lai L
    Discov Med; 2018 Dec; 26(145):251-260. PubMed ID: 30695674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype association and synergistic effect of human aldosterone synthase (CYP11B2) gene polymorphisms causing susceptibility to essential hypertension in Indian patients.
    Vamsi UM; Swapna N; Padma G; Vishnupriya S; Padma T
    Clin Exp Hypertens; 2016; 38(8):659-665. PubMed ID: 27935319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of renin-angiotensin aldosterone system gene polymorphisms in Malaysian essential hypertensive and type 2 diabetic subjects.
    Ramachandran V; Ismail P; Stanslas J; Shamsudin N
    Cardiovasc Diabetol; 2009 Feb; 8():11. PubMed ID: 19243623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Aldosterone Synthase (
    Shah WA; Jan A; Khan MA; Saeed M; Rahman N; Zakiullah ; Afridi MS; Khuda F; Akbar R
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic determination of plasma aldosterone levels in essential hypertension.
    Pojoga L; Gautier S; Blanc H; Guyene TT; Poirier O; Cambien F; Benetos A
    Am J Hypertens; 1998 Jul; 11(7):856-60. PubMed ID: 9683048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone Synthase Promoter Polymorphism and Cardiovascular Phenotypes in a Large, Multiethnic Population-Based Study.
    Byrd JB; Auchus RJ; White PC
    J Investig Med; 2015 Oct; 63(7):862-6. PubMed ID: 26200036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.